372 related articles for article (PubMed ID: 1977759)
1. Clonal origin of pituitary adenomas.
Herman V; Fagin J; Gonsky R; Kovacs K; Melmed S
J Clin Endocrinol Metab; 1990 Dec; 71(6):1427-33. PubMed ID: 1977759
[TBL] [Abstract][Full Text] [Related]
2. Clonal composition of pituitary adenomas in patients with Cushing's disease: determination by X-chromosome inactivation analysis.
Schulte HM; Oldfield EH; Allolio B; Katz DA; Berkman RA; Ali IU
J Clin Endocrinol Metab; 1991 Dec; 73(6):1302-8. PubMed ID: 1720126
[TBL] [Abstract][Full Text] [Related]
3. Clinically nonfunctioning pituitary tumors are monoclonal in origin.
Alexander JM; Biller BM; Bikkal H; Zervas NT; Arnold A; Klibanski A
J Clin Invest; 1990 Jul; 86(1):336-40. PubMed ID: 1973174
[TBL] [Abstract][Full Text] [Related]
4. Clonal composition of benign and malignant human thyroid tumors.
Namba H; Matsuo K; Fagin JA
J Clin Invest; 1990 Jul; 86(1):120-5. PubMed ID: 1973172
[TBL] [Abstract][Full Text] [Related]
5. Molecular screening of pituitary adenomas for gene mutations and rearrangements.
Herman V; Drazin NZ; Gonsky R; Melmed S
J Clin Endocrinol Metab; 1993 Jul; 77(1):50-5. PubMed ID: 8100831
[TBL] [Abstract][Full Text] [Related]
6. Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.
Lidhar K; Korbonits M; Jordan S; Khalimova Z; Kaltsas G; Lu X; Clayton RN; Jenkins PJ; Monson JP; Besser GM; Lowe DG; Grossman AB
J Clin Endocrinol Metab; 1999 Oct; 84(10):3823-30. PubMed ID: 10523037
[TBL] [Abstract][Full Text] [Related]
7. Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease.
Biller BM; Alexander JM; Zervas NT; Hedley-Whyte ET; Arnold A; Klibanski A
J Clin Endocrinol Metab; 1992 Nov; 75(5):1303-9. PubMed ID: 1358909
[TBL] [Abstract][Full Text] [Related]
8. Clonal composition of human adrenocortical neoplasms.
Beuschlein F; Reincke M; Karl M; Travis WD; Jaursch-Hancke C; Abdelhamid S; Chrousos GP; Allolio B
Cancer Res; 1994 Sep; 54(18):4927-32. PubMed ID: 7915195
[TBL] [Abstract][Full Text] [Related]
9. Monoclonality of corticotroph macroadenomas in Cushing's disease.
Gicquel C; Le Bouc Y; Luton JP; Girard F; Bertagna X
J Clin Endocrinol Metab; 1992 Aug; 75(2):472-5. PubMed ID: 1322426
[TBL] [Abstract][Full Text] [Related]
10. [120 biopsies of pituitary adenomas studied by immunohistochemistry and electron microscopy. A clinico-pathological correlation].
Félix IA; Rodríguez Mendoza L; Guinto G; Torres Corzo J; Wussterhaus CA
Gac Med Mex; 1992; 128(3):289-95. PubMed ID: 1302734
[TBL] [Abstract][Full Text] [Related]
11. [Pathology and pathogenesis of pituitary corticotroph adenoma].
Trouillas J
Neurochirurgie; 2002 May; 48(2-3 Pt 2):149-62. PubMed ID: 12058122
[TBL] [Abstract][Full Text] [Related]
12. CDKN2A/p16 inactivation is related to pituitary adenoma type and size.
Seemann N; Kuhn D; Wrocklage C; Keyvani K; Hackl W; Buchfelder M; Fahlbusch R; Paulus W
J Pathol; 2001 Apr; 193(4):491-7. PubMed ID: 11276008
[TBL] [Abstract][Full Text] [Related]
13. Double pituitary lesions in three patients with Cushing's disease.
Meij BP; Lopes MB; Vance ML; Thorner MO; Laws ER
Pituitary; 2000 Nov; 3(3):159-68. PubMed ID: 11383480
[TBL] [Abstract][Full Text] [Related]
14. Molecular pathology shows p16 methylation in nonadenomatous pituitaries from patients with Cushing's disease.
Simpson DJ; McNicol AM; Murray DC; Bahar A; Turner HE; Wass JA; Esiri MM; Clayton RN; Farrell WE
Clin Cancer Res; 2004 Mar; 10(5):1780-8. PubMed ID: 15014032
[TBL] [Abstract][Full Text] [Related]
15. Clonal analysis of human adrenocortical carcinomas and secreting adenomas.
Gicquel C; Leblond-Francillard M; Bertagna X; Louvel A; Chapuis Y; Luton JP; Girard F; Le Bouc Y
Clin Endocrinol (Oxf); 1994 Apr; 40(4):465-77. PubMed ID: 7910530
[TBL] [Abstract][Full Text] [Related]
16. Multihormonal pituitary adenoma concomitant with Pit-1 and Tpit lineage cells causing acromegaly associated with subclinical Cushing's disease: a case report.
Takiguchi T; Koide H; Nagano H; Nakayama A; Fujimoto M; Tamura A; Komai E; Shiga A; Kono T; Higuchi S; Sakuma I; Hashimoto N; Suzuki S; Miyabayashi Y; Ishiwatari N; Horiguchi K; Nakatani Y; Yokote K; Tanaka T
BMC Endocr Disord; 2017 Sep; 17(1):54. PubMed ID: 28865461
[TBL] [Abstract][Full Text] [Related]
17. Clonal analysis using recombinant DNA probes from the X-chromosome.
Vogelstein B; Fearon ER; Hamilton SR; Preisinger AC; Willard HF; Michelson AM; Riggs AD; Orkin SH
Cancer Res; 1987 Sep; 47(18):4806-13. PubMed ID: 2887283
[TBL] [Abstract][Full Text] [Related]
18. Electron microscopical morphometry of pituitary adenomas. Comparison of tumours in acromegaly and hyperprolactinemia.
Saeger W; Kant P; Caselitz J; Lüdecke DK
Pathol Res Pract; 1988 Feb; 183(1):17-24. PubMed ID: 3362748
[TBL] [Abstract][Full Text] [Related]
19. Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms.
Tefferi A; Thibodeau SN; Solberg LA
Blood; 1990 May; 75(9):1770-3. PubMed ID: 1970487
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetic approach to the analysis of clonal proliferation in hematologic disorders.
Morita K; Tsukamoto N; Karasawa M; Omine M
Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1414-22. PubMed ID: 2576494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
